ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model
- 10 February 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 509 (1) , 43-48
- https://doi.org/10.1016/j.ejphar.2004.12.034
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Profound, Non-Opioid Analgesia Produced by the High-Efficacy 5-HT1A Agonist F 13640 in the Formalin Model of Tonic Nociceptive PainPharmacology, 2003
- Gabapentin for Relief of Neuropathic Pain Related to Anticancer Treatment: A Preliminary StudyJournal of Chemotherapy, 2002
- Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in ratsPain, 2000
- ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic painBrain Research, 1998
- Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in miceEuropean Journal of Pharmacology, 1998
- Mono- and Disubstituted-3,8-diazabicyclo[3.2.1]octane Derivatives as Analgesics Structurally Related to Epibatidine: Synthesis, Activity, and ModelingJournal of Medicinal Chemistry, 1998
- Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine ReceptorsScience, 1998
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglionBritish Journal of Pharmacology, 1994
- Nicotinic acetylcholine receptor mRNA in dorsal root ganglion neuronsJournal of Neurobiology, 1991